ORAGENICS, INC. Preferred Stock, Shares Outstanding
ORAGENICS, INC. (OGEN) had Preferred Stock, Shares Outstanding of 7.49 million shares as of 2024-12-31, per its 10-K filed 2025-03-14.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockSharesOutstanding · last filed 2025-03-14
- 2024-12-31: Preferred Stock, Shares Outstanding 7.49M shares.
- 2023-12-31: Preferred Stock, Shares Outstanding 16.97M shares.
- 2017-03-31: Preferred Stock, Shares Outstanding 0.00 shares.
- 2016-12-31: Preferred Stock, Shares Outstanding 0.00 shares.
| Period end | Preferred Stock, Shares Outstanding |
|---|---|
| 2024-12-31 | 7.49M shares 10-K · filed 2025-03-14 |
| 2023-12-31 | 16.97M shares 10-K · filed 2025-03-14 |
| 2017-03-31 | 0.00 shares 10-Q · filed 2017-05-15 |
| 2016-12-31 | 0.00 shares 10-Q · filed 2017-05-15 |
| 2016-09-30 | 0.00 shares 10-Q · filed 2016-11-14 |
| 2016-06-30 | 0.00 shares 10-Q · filed 2016-08-15 |
| 2016-03-31 | 0.00 shares 10-Q · filed 2016-05-16 |
| 2015-12-31 | 0.00 shares 10-K · filed 2017-02-27 |
| 2015-09-30 | 0.00 shares 10-Q · filed 2015-11-06 |
| 2015-06-30 | 0.00 shares 10-Q · filed 2015-08-07 |
| 2015-03-31 | 0.00 shares 10-Q · filed 2015-05-08 |
| 2014-12-31 | 0.00 shares 10-K · filed 2016-03-30 |
| 2014-09-30 | 0.00 shares 10-Q · filed 2014-11-03 |
| 2014-06-30 | 0.00 shares 10-Q · filed 2014-08-07 |
| 2013-12-31 | 0.00 shares 10-K · filed 2015-02-27 |
| 2011-12-31 | 0.00 shares 10-K · filed 2012-04-16 |
| 2011-09-30 | 0.00 shares 10-Q · filed 2011-11-14 |
| 2011-06-30 | 0.00 shares 10-Q · filed 2011-08-05 |
| 2010-12-31 | 0.00 shares 10-K · filed 2012-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |